ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Genomic markers"

  • 2021 American Transplant Congress

    Early Experience with Broad Renal Genetic Testing in an Academic Transplant Center

    E. Tantisattamo1, K. Brossart2, N. Ioannou2, S. McCormick2, P. R. Billings2, H. Tabriziani2

    1Division of Nephrology, Hypertension and Kidney Transplantation, Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine, University of California Irvine School of Medicine, Orange, CA, 2Natera, Inc., San Carlos, CA

    *Purpose: Genetic testing is an emerging tool in kidney transplantation (KT), particularly to assess risk of recurrent disease in patients with KT and for selection…
  • 2021 American Transplant Congress

    Detection of Rejection in Kidney Transplant Patients Using an Algorithm That Combines Donor Fraction and Absolute Donor-derived Cell-free DNA

    S. Bunnapradist1, E. Ahmed2, M. Maninder2, Z. P. Demko2, P. R. Billings2, H. Tabriziani2, P. Gauthier3

    1David Geffen Sch of Med @ UCLA, Los Angeles, CA, 2Natera, Inc., San Carlos, CA, 3Natera, Inc., Los Angeles, CA

    *Purpose: Donor-derived cell-free DNA (dd-cfDNA) in the plasma of renal allograft patients is a clinically validated biomarker for allograft injury and rejection. Several dd-cfDNA assays…
  • 2020 American Transplant Congress

    Tolerant Liver Transplant Patients Have Higher Level of Y RNA Fragments in the Circulation

    C. Kuscu1, A. Wolen1, A. Bajwa1, C. Kuscu1, J. Eason2, B. Ramaswami3, D. Maluf1, G. Mazariegos3, G. Chalasani3, V. Mas1

    1Transplant Research Institute, James D. Eason Transplant Institute, Department of Surgery, University of Tennessee Health Science Center, Memphis, TN, 2James D. Eason Transplant Institute, Department of Surgery, University of Tennessee Health Science Center, Memphis, TN, 3Thomas E. Starzl Transplantation Institute, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA

    *Purpose: Tolerance post transplantation continue to be the ultimate goal in transplantation. Circulating small RNAs are one of the best candidates for biomarker studies. To…
  • 2020 American Transplant Congress

    Discovery and Validation of a Urinary Exosome mRNA Signature for the Diagnosis of Human Kidney Transplant Rejection

    R. El Fekih1, A. Alghamdi1, J. Hurley2, C. Coticchia2, J. Choi1, H. Allos1, S. Eskandari1, S. Bentink2, V. Tadigotla2, L. Riella1, J. Markmann3, K. Safa3, R. Formica4, J. Skog2, J. Azzi1

    1Medecine, Brigham and Women's Hospital, Boston, MA, 2Exosome Diagnostics Inc., Waltham, MA, 3Massachusetts General Hospital, Boston, MA, 4Yale School of Medecine, New Haven, CT

    *Purpose: Monitoring kidney transplant rejection by repeated biopsies might result in increased procedural complications and cost. Exosomes are nanometer-sized vesicles released by cells carrying trans…
  • 2020 American Transplant Congress

    Combining Pharmacy and Genome-Wide Genotyping Data to Examine Medication Regimen Complexity Indices (MRCI), Drug-Drug and Gene-Drug Interactions in Transplant Patients

    L. Callans, J. Obayemi, H. Gao, A. Shaked, B. Chang, B. Keating

    Penn Transplant Institute, Hospital of the University of Pennsylvania, Philadelphia, USA, Philadelphia, PA

    *Purpose: Polypharmacy, typically defined as the use of five or more medications, is a barrier to adherence, and the resulting complex medication regimens result in…
  • 2020 American Transplant Congress

    Role of Genetic Studies in Reclassifying Cause of End Stage Kidney Disease among Kidney Transplant Candidates

    M. El Ters1, F. Pinto e Vairo2, F. C. Fervenza1, M. Alexander3, F. G. Cosio1, H. Amer1, M. Hogan1

    1Division of Nephrology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, 2Department of Clinical Genomics, Mayo Clinic, Rochester, MN, 3Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN

    *Purpose: Recent studies evaluating genetic causes of kidney disease have reclassified a subgroup of focal segmental glomerulosclerosis (FSGS) into collagenopathies. This knowledge has implication in…
  • 2020 American Transplant Congress

    Combined Phenotyping to Identify Kidney Transplants at Greatest Risk after Subclinical Acute Rejection

    S. Park1, R. Heilman2, E. Poggio3, D. Taber4, L. Zhao1, K. Guo1, S. Kurian5, C. Rebello1, S. Brietigam1, M. Abecassis6, J. Friedewald1

    1Northwestern University, Chicago, IL, 2Mayo Clinic, Scottsdale, AZ, 3Cleveland Clinic, Cleveland, OH, 4MUSC, Charleston, SC, 5Scripps, La Jolla, CA, 6University of Arizona, Tucson, AZ

    *Purpose: We hypothesize that the combination of protocol biopsy histology and gene expression profiles (GEP) for subclinical acute rejection (subAR) in the blood will improve…
  • 2020 American Transplant Congress

    Small RNA Extracellular Vesicles Isolated from Liver Perfusate Provides Assessment of Organ Quality and Post Transplantation Graft Function

    A. Bajwa, C. Kuscu, C. Kuscu, A. R. Wolen, J. D. Eason, D. Maluf, V. Mas

    Dept of Surgery, Transplant Research Institute, James D. Eason Transplant Institute, University of Tennessee Health Science Center, Memphis, TN

    *Purpose: Donor quality plays a critical role during IRI and early graft outcomes. Extracellular vesicles (EVs) provide a novel source of valuable biomarkers that may…
  • 2020 American Transplant Congress

    Attempted Validation of Lims1 Variant Rs893403 with Acute Rejection Risk

    W. S. Oetting1, G. Weihua1, C. R. Dorr1, R. B. Mannon2, A. J. Matas1, P. A. Jacobson1, A. K. Israni1

    1University of Minnesota, Minneapolis, MN, 2University of Alabama, Birmingham, AL

    *Purpose: Acute rejection (AR) in kidney allograft recipients is a significant risk factor for reduced graft survival. Identifying individuals at risk for AR could facilitate…
  • 2020 American Transplant Congress

    Circulating MicroRNA Signatures in Chronic Pancreatitis Patients Undergoing Total Pancreatectomy with Islet Transplantation

    S. Vasu, C. M. Darden, K. Kumano, M. Lawrence, B. Naziruddin

    Baylor University Medical Ctr, Dallas, TX

    *Purpose: Chronic pancreatitis (CP) is characterized by exocrine insufficiency and severe abdominal pain. Total pancreatectomy with islet autotransplantation (TPIAT) relieves chronic pain and aids restoration…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 13
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences